Sounds like to me there out of the r&d stage!
Mr. Michael Brennan, MIT's Chairman, said, "We are very appreciative of EPIC's initial order. Also, as previously stated, this agreement with EPIC will provide us with needed funding now that we have emerged from our development stage and a partner that is very familiar with the healthcare industry. This will enable MIT to approach other markets in healthcare in addition to our current exclusive focus on the $3.5 billion food safety segment."